{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:06:43Z","timestamp":1791428803200,"version":"4.3.3"},"reference-count":29,"publisher":"Korean Association for the Study of Intestinal Diseases","issue":"2","license":[{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["irjournal.org"],"crossmark-restriction":true},"short-container-title":["Intest Res"],"published-print":{"date-parts":[[2026,4,30]]},"abstract":"<jats:p>Background\/Aims: Carotegrast methyl is a novel small-molecule drug that inhibits \u03b14 integrin. It is prescribed for up to 6 months in patients with moderate ulcerative colitis who have demonstrated an inadequate response to or intolerance of 5-aminosalicylic acid. However, only a few clinical trials have been conducted to assess its effectiveness. This study aimed to evaluate the efficacy and safety of carotegrast methyl in patients with ulcerative colitis. Methods: This multicenter retrospective study included patients with active ulcerative colitis treated with carotegrast methyl between March 2022 and October 2024. The primary outcome was the clinical remission rate following treatment with carotegrast methyl. Secondary outcomes included the clinical response rate, predictors of clinical remission, ulcerative colitis relapse rate after discontinuing carotegrast methyl, and incidence of adverse events. Results: This study included 62 patients who received carotegrast methyl treatment. The median duration of administration was 84 days, with 48.4% of patients achieving clinical remission at the time of carotegrast methyl discontinuation. In 42 patients with corticosteroid\/advanced therapies-naive disease, the clinical remission rate was 54.8%. Multivariate analysis identified the baseline partial Mayo score as an independent predictor of clinical remission. Among those who achieved clinical remission, 34.8% experienced a relapse with a median time to relapse of 152 days. Adverse events occurred in 8 patients, but none were serious. Conclusions: Carotegrast methyl demonstrated good efficacy and safety, potentially benefiting patients with low baseline disease activity. This drug may be a useful treatment option to consider before systemic corticosteroid therapy for ulcerative colitis.<\/jats:p>","DOI":"10.5217\/ir.2025.00066","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T08:11:06Z","timestamp":1754986266000},"page":"316-328","update-policy":"https:\/\/doi.org\/10.5217\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Real-world effectiveness and safety of carotegrast methyl in patients with ulcerative colitis: a multicenter retrospective cohort study"],"prefix":"10.5217","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6607-0589","authenticated-orcid":true,"given":"Ryoji","family":"Koshiba","sequence":"first","affiliation":[{"name":"2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0564-2793","authenticated-orcid":true,"given":"Kazuki","family":"Kakimoto","sequence":"additional","affiliation":[{"name":"2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Japan"},{"name":"Department of Gastroenterology, Hirakata City Hospital, Hirakata, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9771-141X","authenticated-orcid":true,"given":"Takuya","family":"Inoue","sequence":"additional","affiliation":[{"name":"Inoue Gastroenterology and Endoscopy Clinic, Izumiotsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1789-173X","authenticated-orcid":true,"given":"Makoto","family":"Sanomura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hokusetsu General Hospital, Takatsuki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2462-4983","authenticated-orcid":true,"given":"Mitsuyuki","family":"Murano","sequence":"additional","affiliation":[{"name":"Murano Clinic, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8503-141X","authenticated-orcid":true,"given":"Hiroaki","family":"Ito","sequence":"additional","affiliation":[{"name":"Kinshukai Infusion Clinic, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0609-5812","authenticated-orcid":true,"given":"Yoshihiko","family":"Nakanishi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hirakata City Hospital, Hirakata, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7456-6317","authenticated-orcid":true,"given":"Ken","family":"Kawakami","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Moriguchi Keijinkai Hospital, Moriguchi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8135-2525","authenticated-orcid":true,"given":"Noboru","family":"Mizuta","sequence":"additional","affiliation":[{"name":"2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6081-5287","authenticated-orcid":true,"given":"Keijiro","family":"Numa","sequence":"additional","affiliation":[{"name":"2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8074-2834","authenticated-orcid":true,"given":"Naohiko","family":"Kinoshita","sequence":"additional","affiliation":[{"name":"2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0086-0671","authenticated-orcid":true,"given":"Kei","family":"Nakazawa","sequence":"additional","affiliation":[{"name":"2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6958-7864","authenticated-orcid":true,"given":"Azusa","family":"Hara","sequence":"additional","affiliation":[{"name":"Kinshukai Infusion Clinic, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3686-4690","authenticated-orcid":true,"given":"Yuki","family":"Hirata","sequence":"additional","affiliation":[{"name":"2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3508-1756","authenticated-orcid":true,"given":"Naokuni","family":"Sakiyama","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hokusetsu General Hospital, Takatsuki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4871-5289","authenticated-orcid":true,"given":"Shoko","family":"Arimitsu","sequence":"additional","affiliation":[{"name":"Kinshukai Infusion Clinic, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3255-4932","authenticated-orcid":true,"given":"Takako","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4435-1294","authenticated-orcid":true,"given":"Shiro","family":"Nakamura","sequence":"additional","affiliation":[{"name":"2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0488-3297","authenticated-orcid":true,"given":"Hiroki","family":"Nishikawa","sequence":"additional","affiliation":[{"name":"2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3168","reference":[{"key":"ref1","first-page":"97","volume-title":"Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue","author":"Briskin","year":"1997"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)90015-q"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-011-0104-6"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2147\/ceg.s293272"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v24.i17.1868"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.153.2.517"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1215734"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1215739"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14151"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2013.03.014"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.3978554"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.08.044"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.12.031"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.244"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1159\/000541663"},{"key":"ref16","volume-title":""},{"key":"ref17","first-page":"33","volume-title":"Clinical experiences and predictors of success of treatment with vedolizumab in IBD patients: a cohort study","author":"M\u00fchl","year":"2021"},{"key":"ref18","first-page":"579","volume-title":"Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease","author":"West","year":"2017"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.01.027"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.07.003"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjz154"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11174952"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/cei\/uxad093"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2871"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1136\/gut.40.2.241"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10387-7"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3780164"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-311079"},{"key":"ref29","first-page":"571","volume-title":"Natalizumab: alpha 4-integrin antagonist selective adhesion molecule inhibitors for MS","author":"Rudick","year":"2004"}],"container-title":["Intestinal Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/irjournal.org\/upload\/pdf\/ir-2025-00066.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/irjournal.org\/journal\/view.php?doi=10.5217\/ir.2025.00066","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/irjournal.org\/upload\/pdf\/ir-2025-00066.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T02:07:38Z","timestamp":1778119658000},"score":1,"resource":{"primary":{"URL":"http:\/\/irjournal.org\/journal\/view.php?doi=10.5217\/ir.2025.00066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"URL":"https:\/\/doi.org\/10.5217\/ir.2025.00066","relation":{},"ISSN":["1598-9100","2288-1956"],"issn-type":[{"value":"1598-9100","type":"print"},{"value":"2288-1956","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"2025-04-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-12","order":2,"name":"published","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-30","order":3,"name":"published","label":"Print publication","group":{"name":"publication_history","label":"Publication History"}}]}}